Walgreens Pinworm Medicine

The standard adult dosage for Pyrantel Pamoate is based on body weight. According to the standard clinical guidelines, the recommended dose is 11 mg of pyrantel base per kilogram of body weight (approximately 5 mg per pound).

• Maximum Dose: The total single dose should not exceed 1 gram (1000 mg), regardless of the patient's weight.
• For Pinworms: A single dose is usually administered. Because Pyrantel does not kill pinworm eggs, healthcare providers frequently recommend a second dose 14 days after the first to ensure that any newly hatched worms are eliminated before they can lay more eggs.
• For Roundworms and Hookworms: While a single dose is often effective, some clinical protocols for hookworms may require treatment for three consecutive days depending on the severity of the infection and the specific species involved. Always follow the specific regimen prescribed by your doctor.

Pyrantel is widely used in children, but the dose must be carefully calculated based on weight rather than age.

• Children 2 years and older: The dosage is the same as the adult weight-based calculation: 11 mg/kg (5 mg/lb).
• Children under 2 years: The safety and effectiveness of Pyrantel in children under the age of 2 (or weighing less than 25 lbs/11 kg) have not been established through large-scale clinical trials. Parents should consult a pediatrician before administering this medication to infants or toddlers. A doctor will perform a risk-benefit analysis to determine if the treatment is appropriate.

Renal Impairment

Because Pyrantel is poorly absorbed and primarily eliminated through the feces, significant dosage adjustments are typically not required for patients with mild to moderate kidney disease. However, patients with severe renal failure should be monitored closely, as the small absorbed fraction is cleared by the kidneys.

Hepatic Impairment

Pyrantel should be used with extreme caution in patients with pre-existing liver disease or hepatic dysfunction. Although systemic absorption is low, the absorbed portion is processed by the liver. Patients with elevated liver enzymes or cirrhosis may have altered clearance of the drug, potentially increasing the risk of systemic side effects.

Elderly Patients

Clinical studies of Pyrantel did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the lower end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.

To ensure the medication works effectively and to minimize discomfort, follow these guidelines:

• Administration: Pyrantel can be taken at any time of day. It does not require fasting or a special diet before or after the dose. However, taking it with milk or fruit juice may improve the taste of the liquid form.
• Liquid Form: Always shake the oral suspension well before measuring a dose. Use a calibrated measuring device (oral syringe or dosing cup) rather than a household teaspoon to ensure accuracy.
• Chewable Tablets: These must be chewed thoroughly before swallowing; they should not be swallowed whole.
• Hygiene Measures: Because pinworms are easily spread, it is often recommended that the entire household be treated at the same time. Additionally, patients should wash all bed linens, towels, and undergarments in hot water on the day of treatment and again after the second dose.
• Storage: Store Pyrantel at room temperature (between 59°F and 86°F or 15°C and 30°C). Keep the container tightly closed and protected from light.

Since Pyrantel is typically taken as a single dose (or a single dose followed by another two weeks later), a 'missed dose' usually refers to forgetting the second follow-up dose. If you forget the second dose, take it as soon as you remember. If it has been more than a few days past the 14-day mark, consult your healthcare provider to see if the treatment cycle needs to be restarted.

Symptoms of a Pyrantel overdose are generally related to an exaggeration of its side effects. Signs may include:

• Severe nausea and vomiting
• Abdominal cramping
• Diarrhea
• Dizziness or lightheadedness
• Tremors or muscle weakness (rare)

In the event of a suspected overdose, contact your local Poison Control Center (1-800-222-1222 in the U.S.) or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining hydration and managing gastrointestinal symptoms.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or treat yourself for a parasitic infection without a confirmed diagnosis.

Because Pyrantel acts locally within the digestive tract and has limited systemic absorption, most side effects are gastrointestinal in nature. These effects are usually mild and temporary, occurring as the body reacts to the medication and the expulsion of the parasites.

• Nausea and Vomiting: This is the most frequently reported side effect. It may occur shortly after taking the medication. Taking the dose with a small snack or milk can often mitigate this.
• Abdominal Cramps: As the paralyzed worms are moved through the intestines by peristalsis, some patients experience mild to moderate cramping or 'tugging' sensations in the mid-section.
• Diarrhea: Loose stools may occur as the body works to flush out the parasites and the unabsorbed medication.
• Anorexia (Loss of Appetite): Some patients may feel a temporary disinterest in food for 24–48 hours following the dose.

While less frequent, some patients may experience systemic reactions due to the small amount of drug that enters the bloodstream or as a secondary reaction to the dying parasites (Herxheimer-like reaction).

• Headache: Mild tension-type headaches have been reported.
• Dizziness and Drowsiness: Some individuals may feel slightly lightheaded or unusually tired. Caution should be exercised when driving until you know how the drug affects you.
• Insomnia: Conversely, some patients report difficulty falling asleep or staying asleep on the night of treatment.
• Skin Rash: A mild, itchy rash (urticaria) may develop in sensitive individuals.

Rarely, more significant reactions can occur. These often require a consultation with a healthcare provider to ensure they are not signs of a more serious underlying issue.

• Elevated Liver Enzymes: In very rare cases, transient increases in AST or ALT (liver function tests) have been noted, though these typically resolve without intervention.
• Tenesmus: A persistent, painful urge to evacuate the bowels, even when the bowels are empty.
• Paresthesia: Tingling or 'pins and needles' sensations in the extremities.
• Hallucinations or Confusion: Extremely rare and usually associated with accidental massive overdose or pre-existing neurological conditions.

While Pyrantel is generally considered very safe, certain symptoms indicate a medical emergency or a severe allergic reaction.

> Warning: Stop taking Pyrantel and call your doctor immediately if you experience any of these:

• Anaphylaxis (Severe Allergic Reaction): Symptoms include swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe wheezing; and a rapid, weak pulse.
• Severe Skin Reactions: Blistering, peeling, or a widespread red rash that could indicate a serious dermatological reaction.
• Extreme Dizziness or Fainting: This could indicate a drop in blood pressure or an idiosyncratic systemic reaction.
• Persistent High Fever: While a low-grade fever can occur as parasites die, a high fever (over 102°F) should be evaluated by a professional.
• Severe Abdominal Pain: Pain that is sharp, localized, or worsening rather than typical cramping may indicate an intestinal blockage if the worm burden is very high.

Pyrantel is intended for short-term, acute use (usually one or two doses). There are no documented long-term side effects associated with the standard use of this medication. It does not accumulate in the body's tissues. However, repeated, frequent use without medical supervision is discouraged, as it may lead to changes in the gut microbiome or mask a more serious underlying infection that requires different medication.

No FDA black box warnings for Pyrantel. The drug has a long-standing safety record when used as directed for its approved indications. It is not associated with the severe risks (such as suicidality or organ failure) that necessitate black box labeling.

Report any unusual symptoms or persistent side effects to your healthcare provider. Even mild side effects should be noted if they interfere with your daily activities or do not resolve within 72 hours of treatment.

Pyrantel is a potent medication and should be treated with the same respect as any prescription drug, even when purchased over-the-counter. The most critical safety point is ensuring an accurate diagnosis. Many gastrointestinal symptoms mimic parasitic infections; taking Pyrantel for a non-parasitic condition will not provide relief and may delay proper treatment. Furthermore, because pinworms are highly transmissible through the fecal-oral route, treating only the symptomatic individual often leads to reinfection. Healthcare providers typically recommend a 'whole-house' approach to treatment and hygiene.

No FDA black box warnings for Pyrantel. It is considered one of the safer anthelmintic options available, which is why it is permitted for OTC sale in many regions.

• Allergic Reactions / Anaphylaxis Risk: While rare, hypersensitivity to Pyrantel Pamoate or any of the inactive ingredients (such as preservatives or flavorings in the liquid form) can occur. If you have a history of multiple drug allergies, discuss this with your pharmacist before use.
• Liver Disease (Hepatotoxicity): As mentioned in the clinical overview, Pyrantel is partially metabolized by the liver. Patients with cirrhosis, hepatitis, or other forms of hepatic impairment should only use Pyrantel under strict medical supervision. There is a theoretical risk that reduced liver function could lead to higher-than-intended systemic levels of the drug.
• Severe Malnutrition or Anemia: In patients with heavy hookworm or roundworm infestations, the parasites themselves cause significant health issues. In these cases, the rapid expulsion of worms should be part of a broader medical plan that includes nutritional support and iron supplementation.
• Intestinal Obstruction: In cases of extremely high 'worm burden' (large numbers of Ascaris roundworms), the paralysis of the worms can theoretically lead to a physical mass that obstructs the bowel. Patients with suspected heavy infestations should be treated in a clinical setting where they can be monitored for signs of obstruction.

For standard pinworm treatment in otherwise healthy individuals, routine lab monitoring is generally not required. However, in specific clinical scenarios, your doctor may order:

• Stool Examination: To confirm the presence of parasites before treatment and to verify their absence 2–4 weeks after treatment.
• Complete Blood Count (CBC): To check for eosinophilia (a high count of a specific type of white blood cell often seen with parasites) or to monitor for anemia in hookworm cases.
• Liver Function Tests (LFTs): If the patient has a history of liver issues or if high doses are required.

Pyrantel may cause dizziness or somnolence (drowsiness) in a small percentage of patients. It is recommended that you observe your reaction to the medication for several hours before driving, operating heavy machinery, or engaging in activities that require mental alertness.

There are no known direct chemical interactions between Pyrantel and alcohol. However, alcohol can irritate the gastrointestinal tract and may worsen the nausea or abdominal cramping associated with the medication. It is generally advisable to avoid alcohol for 24 hours after taking the dose to allow your digestive system to recover.

Since Pyrantel is usually a single-dose treatment, 'discontinuation' is not typically an issue. However, you should not stop the recommended hygiene measures or skip the second follow-up dose (if prescribed) just because symptoms have improved. Failure to complete the full recommended protocol (including the 14-day follow-up) significantly increases the risk of reinfection.

> Important: Discuss all your medical conditions, especially liver disease or severe allergies, with your healthcare provider before starting Pyrantel.

• Piperazine: This is the most significant drug interaction for Pyrantel. Piperazine is another anthelmintic medication. While Pyrantel causes spastic paralysis (rigid contraction) of the worms, Piperazine causes flaccid paralysis (limpness). When used together, these two drugs act antagonistically—they essentially cancel each other out. This results in reduced efficacy for both medications, and the parasites may not be eliminated. Never combine these two treatments.

• Theophylline: Some clinical data suggest that Pyrantel may slightly increase the systemic levels of theophylline (a medication used for asthma and COPD) by interfering with its clearance. While the interaction is usually mild due to the low absorption of Pyrantel, patients on theophylline should monitor for signs of theophylline toxicity, such as tremors, rapid heartbeat, or severe nausea, and consult their doctor.

• Other Anthelmintics (e.g., Albendazole, Mebendazole): While sometimes used together in specialized tropical medicine settings to treat multiple types of infections, combining these should only be done under the direction of an infectious disease specialist. There is a potential for increased gastrointestinal side effects.
• Gastric Motility Agents (e.g., Metoclopramide): Drugs that significantly speed up the movement of the intestines may reduce the time Pyrantel spends in contact with the parasites, potentially reducing its effectiveness.

• High-Fat Meals: While Pyrantel can be taken with or without food, extremely high-fat meals might theoretically increase the systemic absorption of the drug. To keep the drug concentrated in the gut where it belongs, standard meals are preferred over very greasy or fatty foods.
• Dairy: There is no evidence that dairy products interfere with Pyrantel; in fact, taking the liquid form with milk is a common way to improve its palatability for children.

• St. John's Wort: While St. John's Wort affects many drugs metabolized by the liver, its interaction with Pyrantel is likely negligible due to Pyrantel's low systemic presence. However, always inform your doctor of herbal use.
• Laxatives: Do not take laxatives while taking Pyrantel unless specifically instructed by your doctor. Pyrantel needs time to act on the worms; inducing rapid bowel movements with a laxative may expel the drug before it has paralyzed the parasites.

• Liver Function Tests: Pyrantel may cause a transient, minor elevation in serum transaminases (AST/ALT). If you are scheduled for blood work shortly after taking Pyrantel, inform your healthcare provider so they can accurately interpret the results.
• Stool Tests for Ova and Parasites (O&P): The medication will obviously affect the results of these tests. Typically, doctors wait at least 2 weeks after treatment to perform a follow-up stool test to ensure the infection is fully cleared.

For each major interaction, the management strategy is generally to avoid the combination (in the case of Piperazine) or to monitor for increased side effects. Because Pyrantel's systemic footprint is so small, it is generally considered to have a very low 'interaction burden' compared to other systemic medications.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for asthma or other chronic conditions.

There are very few absolute contraindications for Pyrantel, but they must be strictly observed to ensure patient safety:

• Hypersensitivity to Pyrantel Pamoate: If a patient has a known allergy to Pyrantel or any component of the formulation (such as specific dyes or flavorings in the suspension), the drug must NEVER be used. An allergic reaction can range from a mild rash to life-threatening anaphylaxis. The mechanism of this contraindication is an IgE-mediated immune response to the drug molecule.
• Piperazine Co-administration: As detailed in the interactions section, the use of Piperazine alongside Pyrantel is contraindicated because their opposing mechanisms of action (spastic vs. flaccid paralysis) neutralize the therapeutic benefit, potentially allowing the parasitic infection to persist and worsen.

Relative contraindications require a careful risk-benefit analysis by a healthcare professional:

• Severe Hepatic Impairment: Patients with advanced liver disease (e.g., Child-Pugh Class C) should use Pyrantel with extreme caution. Although absorption is low, any drug that enters the system must be processed by the liver. In a compromised liver, even small amounts could theoretically accumulate, leading to systemic toxicity.
• Severe Malnutrition: In patients who are severely debilitated or malnourished, the physiological stress of a parasitic infection and its subsequent treatment must be managed carefully. Dehydration from potential diarrhea (a side effect) could be more dangerous in this population.
• Pregnancy (First Trimester): While not strictly contraindicated, many doctors prefer to delay treatment until after the first trimester unless the infection poses a significant risk to the mother's health, due to the general caution regarding drug exposure during organogenesis.

There is no significant evidence of cross-sensitivity between Pyrantel and other common classes of anthelmintics like the benzimidazoles (Albendazole, Mebendazole). However, patients who have had reactions to other pyrimidine derivatives should be monitored closely for similar allergic responses.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of liver issues or severe drug allergies, before prescribing or recommending Pyrantel.

Pyrantel is classified by the FDA as Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women.

• Risk Assessment: Because Pyrantel is poorly absorbed from the GI tract, the systemic exposure to the fetus is likely very low. However, the general medical consensus is that Pyrantel should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus.
• Timing: If treatment is necessary, many healthcare providers recommend waiting until the second or third trimester to avoid any potential (though unproven) risks during the critical first-trimester development phase.

It is not known whether Pyrantel is excreted in human milk. However, because of the drug's very poor oral absorption, it is unlikely that significant amounts would reach the bloodstream of the mother, and even less likely that it would be present in breast milk in quantities that would affect a nursing infant.

• Clinical Recommendation: Most experts consider Pyrantel to be compatible with breastfeeding, but mothers should consult their doctor. Monitoring the infant for any changes in bowel habits or skin rashes is a prudent precaution.

• Approved Age: Pyrantel is commonly used in children aged 2 and older. It is one of the few anthelmintics available over-the-counter for pediatric pinworm infections.
• Growth and Development: There is no evidence that a single or double dose of Pyrantel affects long-term growth or development in children.
• Safety in Infants: For children under 2 years of age or weighing less than 25 lbs, the drug should only be used under the direct supervision of a pediatrician. The primary concern in very young children is the risk of choking on tablets or the difficulty in managing potential gastrointestinal side effects like vomiting, which can quickly lead to dehydration in infants.

Elderly patients can safely use Pyrantel, but several age-related factors should be considered:

• Renal and Hepatic Function: Since older adults are more likely to have decreased liver or kidney function, they should be monitored for systemic side effects, even though absorption is low.
• Polypharmacy: Seniors often take multiple medications. While Pyrantel has few interactions, the risk of stomach upset may be higher in patients taking other GI-irritating drugs like NSAIDs (e.g., ibuprofen).
• Fall Risk: If a geriatric patient experiences the less common side effect of dizziness, it could significantly increase their risk of falls.

Specific GFR-based (Glomerular Filtration Rate) dose adjustments are not officially established for Pyrantel due to its low systemic absorption. However, clinicians should exercise caution in patients with end-stage renal disease. Pyrantel is not known to be cleared by dialysis, so supplemental doses after dialysis are not required.

Patients with hepatic impairment (Child-Pugh A, B, or C) require individualized assessment. While the drug acts locally, the small absorbed fraction requires hepatic metabolism. In patients with significant liver dysfunction, the healthcare provider may choose to monitor liver enzymes more closely following administration.

> Important: Special populations, particularly pregnant women and those with liver disease, require an individualized medical assessment before using Pyrantel.

Pyrantel Pamoate is a depolarizing neuromuscular blocking agent. Its primary target is the nicotinic acetylcholine receptor (nAChR) located on the somatic muscle cells of susceptible nematodes.

• Molecular Detail: Pyrantel acts as a potent agonist at these receptors, mimicking the action of acetylcholine but with much greater persistence. This leads to a continuous opening of cation channels, resulting in an influx of sodium and calcium ions.
• Result: This persistent depolarization causes a spastic (rigid) paralysis of the parasite's musculature. Additionally, Pyrantel has been shown to inhibit acetylcholinesterase, the enzyme responsible for breaking down acetylcholine, which further intensifies the paralyzing effect. The paralyzed worms lose their ability to maintain their position in the host's intestinal tract and are expelled by normal bowel movements.

• Dose-Response: The anthelmintic effect of Pyrantel is dose-dependent up to the recommended maximum of 11 mg/kg. Higher doses do not significantly increase the cure rate but do increase the risk of systemic side effects.
• Time to Onset: The drug begins acting on the parasites within hours of ingestion as it moves through the GI tract. However, the physical expulsion of the worms in the stool may take 1 to 3 days.
• Duration: The effect lasts as long as the drug is present in the intestinal lumen. Since it is not well-absorbed, its 'duration of action' is essentially the transit time of the digestive system.

| Parameter | Value |

|---|---|

| Bioavailability | < 15% (Systemic) |

| Protein Binding | Not significantly characterized in humans |

| Half-life | Not precisely defined (due to low systemic levels) |

| Tmax | 1–3 hours (for the small absorbed fraction) |

| Metabolism | Partial hepatic metabolism |

| Excretion | Fecal (>50% unchanged), Renal (minor fraction) |

• Molecular Formula: $C_{11}H_{14}N_2S \cdot C_{23}H_{16}O_6$ (Pyrantel Pamoate)
• Molecular Weight: 594.7 g/mol (combined salt form)
• Solubility: Pyrantel Pamoate is practically insoluble in water and methyl alcohol. This low solubility is a key factor in its poor intestinal absorption.
• Structure: It consists of a pyrimidine ring linked to a thiophene ring, paired with the large pamoic acid (embonic acid) molecule which serves to keep the drug in the salt form within the gut.

Pyrantel is classified as an Anthelmintic within the pyrimidine derivative sub-class. It is therapeutically related to other anti-parasitic agents like Levamisole, though it is generally considered to have a superior safety profile for human use in the treatment of common intestinal nematodes.